Abstract
Background
Mucosal alterations after Roux-en-Y gastric bypass for morbid obesity have not been clearly evaluated. This study aims to analyze the mucosal alterations (proliferative status (Ki-67); apoptosis (caspase-3 and BCL-2); hormonal function (gastrin)) in the excluded stomach.
Methods
Double-balloon enteroscopy was performed in 35 patients who underwent Roux-en-Y gastric bypass longer than 36 months. Multiple biopsies of the proximal pouch and the excluded gastric mucosa were collected. Gastric biopsies from 32 non-operated obese patients were utilized as controls. Endoscopic biopsies were cut from tissue blocks fixed in formalin and embedded in paraffin. Sections 4 μm thick were examined for immunoexpression using the streptavidin–biotin–peroxidase method.
Results
The two groups were comparable for age, gender, gastritis, intestinal metaplasia, and Helicobacter pylori. The mean number of positive gastrin cells was 55.5 (standard deviation (SD) = 11.7) in the control group and 29.6 (SD = 7.9) in the cases, p = 0.0003. Ki-67 proliferative index in cases (body = 24.7 %, antrum = 24.9 %) was significantly higher compared to controls (body = 15.0 % and antrum = 17.7 %), p = 0.002 and 0.01, respectively. Caspase-3 immunoexpression was higher in the controls compared to the excluded stomach (46 vs. 31 %), p = 0.02. There was no statistical difference between CD3, CD8, and Bcl-2 immunoexpressions in the control and cases.
Conclusions
Cell proliferation is increased and apoptosis is downregulated in the excluded gastric mucosa compared to the non-operated obese controls. Alterations in cell turnover and in hormonal secretions in these conditions may be of relevance in long-term follow-up.
Similar content being viewed by others
References
Weber M, Clavien PA. Bariatric surgery—a successful way to battle the weight crisis. Br J Surg. 2006;93:259–60.
Consensus Development Conference Panel. Gastrointestinal surgery for severe obesity. Ann Intern Med. 1991;115:956–61.
Capella RF, Capella JF, Mandec H, et al. Vertical banded gastroplasty-gastric bypass: preliminary report. Obes Surg. 1991;1(4):389–95.
Sakai P, Kuga R, Safatle-Ribeiro AV, et al. Is it feasible to reach the bypassed stomach after Roux-en-Y gastric bypass for morbid obesity? The use of the double-balloon enteroscope. Endoscopy. 2005;37:566–9.
Fobi MA, Chicola K, Lee H. Access to the bypassed stomach after gastric bypass. Obes Surg. 1998;8(3):289–95.
Goitein D, Gagné DJ, Papasavas PK, et al. Percutaneous computed tomography-guided gastric remnant access after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2(6):651–5.
Silecchia G, Catalano C, Gentileschi P, et al. Virtual gastroduodenoscopy: a new look at the bypassed stomach and duodenum after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg. 2002;12(1):39–48.
Sundbom M, Hedenstrom H, Gustavsson S. Duodenogastric bile reflux after gastric bypass: a cholescintigraphic study. Dig Dis Sci. 2002;47:1891–6.
Safatle-Ribeiro AV, Kuga R, Iriya K, et al. What to expect in the excluded stomach mucosa after vertical banded Roux-en-Y gastric bypass for morbid obesity. J Gastrointest Surg. 2007;11(2):133–7.
Kuga R, Safatle-Ribeiro AV, Faintuch J, et al. Endoscopic findings in the excluded stomach after Roux-en-Y gastric bypass surgery. Arch Surg. 2007;142(10):942–6.
Faintuch J, Ishida RK, Jacabi M, et al. Increased gastric cytokine production after Roux-en-Y gastric bypass for morbid obesity. Arch Surg. 2007;142(10):962–8.
Ishida RK, Faintuch J, Paula AM, et al. Microbial flora of the stomach after gastric bypass for morbid obesity. Obes Surg. 2007;17(6):752–8. Erratum in: Obes Surg. 2007 Jul;17(7):996.
Raijman I, Strother SV, Donegan WL. Gastric cancer after gastric bypass for obesity. Case report. J Clin Gastroenterol. 1991;13(2):191–4.
Lord RV, Edwards PD, Coleman MJ. Gastric cancer in the bypassed segment after operation for morbid obesity. Aust N Z J Surg. 1997;67(8):580–2.
Khitin L, Roses RE, Birkett DH. Cancer in the gastric remnant after gastric bypass: a case report. Curr Surg. 2003;60(5):521–3.
Escalona A, Guzman S, Ibanez L, et al. Gastric cancer after Roux-en-Y gastric bypass. Obes Surg. 2005;15(3):423–7.
Trincado MT, del Olmo JC, Garcia Castano J, et al. Gastric pouch carcinoma after gastric bypass for morbid obesity. Obes Surg. 2005;15(8):1215–7.
Corsini DA, Simoneti CA, Moreira G, et al. Cancer in the excluded stomach 4 years after gastric bypass. Obes Surg. 2006;16(7):932–4.
Harper JL, Beech D, Tichansky DS, et al. Cancer in the bypassed stomach presenting early after gastric bypass. Obes Surg. 2007;17(9):1268–71.
Watkins BJ, Blackmun S, Kuehner ME. Gastric adenocarcinoma after Roux-en-Y gastric bypass: access and evaluation of excluded stomach. Surg Obes Relat Dis. 2007;3(6):644–7.
Clarke MR, Safatle-Ribeiro AV, Ribeiro U, et al. Bcl-2 protein expression in gastric remnant mucosa and gastric cancer 15 or more years after partial gastrectomy. Mod Pathol. 1997;10:1021–7.
Safatle-Ribeiro AV, Ribeiro Jr U, Sakai P, et al. Integrated p53 histopathologic/genetic analysis of premalignant lesions of the esophagus. Cancer Detect Prev. 2000;24(1):13–23.
Cattoretti G, Becker MH, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol. 1992;168:357–63.
Yang L, Wu DY, Xin Y. Down-regulation of caspase-3 expression in precancerous lesions and its relation to gastric carcinogenesis. Zhonghua Zhong Liu Za Zhi. 2006;28(5):357–60.
Beckman LM, Beckman TR, Earthman CP. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review. J Am Diet Assoc. 2010;110(4):571–84.
Dalcanale L, Oliveira CP, Faintuch J, et al. Long-term nutritional outcome after gastric bypass. Obes Surg. 2010;20(2):181–7.
Hedberg J, Hedenström H, Nilsson S, et al. Role of gastric acid in stomal ulcer after gastric bypass. Obes Surg. 2005;15(10):1375–8.
Leme PLS, Malheiros CA, Rodrigues FCM, et al. Gastroduodenal exclusion and truncal vagotomy: weight and seric gastrin alterations. Experimental study on rats. Rev Col Bras Cir. 2003;30(6):416–23.
Anderi Jr E, Rossi FM, Souza CK, et al. Estudo da gastrinemia pré e pós-operatória em pacientes submetidos à gastroplastia vertical ncom banda e reconstrução em Y de Roux por obesidade mórbida. Rev Col Bras Cir. 2008;35(5):392–6.
Correa P. Human gastric carcinogenesis: a multistep and multifactorial process—first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res. 1992;52:6735–40.
Shiotani A, Iishi H, Ishiguro S, et al. Epithelial cell turnover in relation to ongoing damage of the gastric mucosa in patients with early gastric cancer: increase of cell proliferation in pre-malignant lesions. J Gastroenterol. 2005;40(4):337–44.
Csendes A, Burdiles P, Papapietro K, et al. Results of gastric bypass plus resection of the distal excluded gastric segment in patients with morbid obesity. J Gastrointest Surg. 2005;9(1):121–31.
Madan AK, Lanier BJ, Tichansky DS, et al. Laparoscopic Roux-en-Y gastric bypass with subtotal gastrectomy. Obes Surg. 2005;15(9):1332–5.
Braghetto I, Csendes A, Korn O, et al. Laparoscopic resectional gastric bypass in patients with morbid obesity: experience on 112 consecutive patients. J Gastrointest Surg. 2011;15(1):71–80.
Menéndez P, Padilla D, Villarejo P, et al. Does bariatric surgery decrease gastric cancer risk? Hepatogastroenterology. 2012;59(114):409–12.
Safatle-Ribeiro AV, Ribeiro Jr U, Reynolds JC. Gastric stump cancer: what is the risk? Dig Dis. 1998;16(3):159–68.
Sinning C, Schaefer N, Standop J, et al. Gastric stump carcinoma—epidemiology and current concepts in pathogenesis and treatment. Eur J Surg Oncol. 2007;33(2):133–9.
Acknowledgments
The authors thank Thaise Yumie Tomokani and Bruna Souza de Quevedo for their technical assistance. This work was supported by a grant from the Foundation of Support to the Research of the State of São Paulo (FAPESP, no. 06/537414).
Conflict of Interest
The authors of this manuscript—Adriana V. Safatle-Ribeiro, M.D., PhD; Pedro A. Petersen, M.D.; Dilson S. Pereira Filho, M.D.; Carlos E. P. Corbett, M.D., PhD; Joel Faintuch, M.D., PhD; Robson Ishida, M.D.; Paulo Sakai, M.D., PhD; Ivan Cecconello, M.D., PhD; and Ulysses Ribeiro Jr. M.D., PhD—have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Safatle-Ribeiro, A.V., Petersen, P.A., Pereira Filho, D.S. et al. Epithelial Cell Turnover Is Increased in the Excluded Stomach Mucosa After Roux-en-Y Gastric Bypass for Morbid Obesity. OBES SURG 23, 1616–1623 (2013). https://doi.org/10.1007/s11695-013-0975-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-013-0975-2